Apply now to join a UK trade mission to Japan this October. Meet potential partners, explore the growing bioeconomy, and attend the BioJapan conference.
The MHRA is now accepting applications for phase 2 of its AI Airlock – a regulatory sandbox for testing and evaluating AI Medical Devices (AIaMD) in a safe, controlled environment.
LifeArc's newly launched B-SMArT antibody discovery platform offers collaborators a clinically validated transgenic mouse model (Kymab/Sanofi) and advanced single B-cell selection technologies (Beacon and FACS) to generate fully human antibodies ready for in vivo testing.
This nationwide initiative is calling on companies, teams, and individuals to commit to a fitness challenge while raising vital funds for translational cancer research—helping life-saving innovations move from the lab to patients faster.
